SEC Filing Update: #SABS SAB Biotherapeutics, Inc. : $3.57

Sector: Healthcare | YTD: 🔽 -4.80% The SEC disclosed Today (14-AUG-2026) that Vivo Opportunity Fund Holdings, L.P. has DECREASED #SABS Shares by -12.70% 🔴 BALYASNY ASSET MANAGEMENT LLC also reported an increase in its holdings on the same day. WOODLINE PARTNERS LP also reported an increase in its holdings on the same day. * Previous Holdings: 25.93M Shares * Current Holdings: 22.64M Shares * Decrease -3.29M * Decreased (%)-12.70% * Ownership: 9.99% https://www.thinksabio.com/reports/isr/SABS Institutional ownership in #SABS has been steadily rising over the past 4 quarters in Shares: Q2 2025: 1.92M Q3 2025: 28.02M Q4 2025: 36.34M Q1 2026: 69.19M 📌 Institutional activity in the last 30 days for #SABS: • RA CAPITAL MANAGEMENT – Increased holdings by 5,208,352 shares (10-AUG-2026) • Adage Capital Management, L.P. – Newly bought 6,405,553 shares (12-AUG-2026) • BALYASNY ASSET MANAGEMENT LLC – Increased holdings by 2,135,500 shares (14-AUG-2026) • WOODLINE PARTNERS LP – Increased holdings by 4,275,000 shares (14-AUG-2026)